Heron Therapeutics Stock (NASDAQ: HRTX) stock price, news, charts, stock research, profile.
Open | $2.740 |
Close | $2.770 |
Volume / Avg. | 1.107M / 3.071M |
Day Range | 2.670 - 2.810 |
52 Wk Range | 0.500 - 3.220 |
Market Cap | $408.939M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 19.48% |
Days to Cover | 6.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Heron Therapeutics (NASDAQ: HRTX) through any online brokerage.
Other companies in Heron Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Humacyte (NASDAQ:HUMA), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY) and Celcuity (NASDAQ:CELC).
The latest price target for Heron Therapeutics (NASDAQ: HRTX) was reported by Needham on Wednesday, March 13, 2024. The analyst firm set a price target for 5.00 expecting HRTX to rise to within 12 months (a possible 83.80% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $2.7203 last updated March 28, 2024 at 7:18 PM EDT.
There are no upcoming dividends for Heron Therapeutics.
Heron Therapeutics’s Q4 earnings are confirmed for Monday, February 27, 2023.
There is no upcoming split for Heron Therapeutics.
Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.